Prescribing Patterns and Costs Associated with Postoperative Eye Drop Use in Medicare Beneficiaries Undergoing Cataract Surgery

Medicine & Life Sciences

• Ophthalmic Solutions 100%
• Medicare 87%
• Cataract 79%
• Costs and Cost Analysis 52%
• Drug Substitution 49%
• Generic Drugs 23%
• Prescriptions 14%
• Medicare Part D 13%
• Centers for Medicare and Medicaid Services (U.S.) 10%
• Physicians 10%
• Cost Savings 9%
• Postoperative Period 8%
• Statistical Factor Analysis 7%
• Pharmaceutical Preparations 7%
• Therapeutic Uses 7%
• Income 6%
• Steroids 6%
• Anti-Inflammatory Agents 6%
• Anti-Bacterial Agents 5%
• Health Care Outcome Assessment 5%
• Cross-Sectional Studies 5%